24 May 2022 / Adam Ang / MobiHealth News The company develops a breakthrough device for detecting residual cancer tissues. OncoRes medical device. (Supplied) Excerpt from article: Perth-based medical device firm OncoRes Medical has bagged $12.5 million in funding to support its upcoming clinical trials. It recently scored $9.5 million in a Series A2 funding co-led by VC Brandon Capital and Future of Healthcare Fund by Australian Unity. A separate $3 million funding was se

Wednesday, 18 May 2022 / Liam Wignell / Startup News OncoRes Medical chief commercial officer Simon Graindorge with CEO Katharine Giles. Image supplied. Excerpt from article: Perth-based OncoRes Medical has announced $12.5 million in funding to advance its innovative imaging system that facilities real-time tumour assessment to assist surgeons in identifying and removing cancerous tissue such as breast cancer. Australian and New Zealand VC Brandon Capital, manager of the

Wednesday, 18 May 2022 OncoRes Team. Photo by Rob Johnson. OncoRes Medical’s imaging system may be a game-changer for breast cancer...

Monday, 16 June 2021 / Matt Mckenzie / Business News Female researchers and entrepreneurs have powered many of WA’s health care advancements Kath Giles has worked in the operating theatre and the boardroom. Photo: David Henry Kath Giles is excited about a decision taken by US medical regulators in early May. OncoRes Medical, the business Dr Giles leads as chief executive, secured a special approval from the US Food and Drug Administration for a device designed to help fig

Friday, 14 May 2021 / Nancy Crotti / Medical Design and Outsourcing OncoRes Medical’s system may detect cancer cells on a microscopic scale during a lumpectomy, potentially averting the need for a second breast cancer surgery. Combining optical coherence tomography imaging (OCT; left) with micro-elastography technologies, OncoRes’ quantitative micro-elastography (QME) imaging system provides real-time tumor assessment that helps surgeons more accurately identify and remov

Monday, 3 May 2021 OncoRes Medical has received ‘Breakthrough Device Designation’ from the U.S. Food and Drug Administration (FDA) to...

Tuesday, 9 March 2021 / Australian Investment Council In the second part of the Invest Week digital series, Yasser is joined by Dr Kath...

Friday, 22 January 2021 OncoRes team (L-R): Ruedi Hauri, Cosimo Santella and Teddy Yeo Innovation and ICT Minister Dave Kelly today...

Thursday, 29 October 2020 Perth-based medtech company, OncoRes Medical, has taken out the IGNITE Madness pitch competition in Houston,...

Wednesday, 29 July 2020 / Charles Gunningham / Startup News Perth-based medtech OncoRes Medical has been awarded $1 million funding as part of the Australian Government’s Medical Research Future Fund BioMedTech Horizons program, operated by MTPConnect. Image: Dr Kath Giles, CEO of OncoRes Medical Excerpt from article: Kath Giles’ medtech company OncoRes Medical , which famously won the global Pitch@Palace competition 18 months ago, has been awarded a $1M federal governm

Monday, 20 July 2020 Perth-based medtech company, OncoRes Medical, has been awarded $1 million funding as part of the Australian...

Wednesday, 15 April 2020 Abstract Inadequate margins in breast-conserving surgery (BCS) are associated with an increased likelihood of...

Thursday, 31 October 2019 / AusBiotech Kath Giles and Dr Christobel Saunders (centre) Winners of Emerging Company of the Year Inaugural AusBiotech Life Sciences Legacy Award: Mr Chuck Feeney AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards Industry Leadership Award: Sue MacLeman Company of the Year: PolyNovo Emerging Company of the Year: OncoRes Medical Emerging Company of the Year: OncoRes Medical OncoRes Medical, led by Dr Kath Giles, CEO and Managin

Wednesday, 30 October 2019 / By Colin Miller / MedTech Strategist The treatment of breast cancer today commonly entails repeat breast conserving surgeries due to imprecise methods of locating and measuring tumors during surgery. These lead to unnecessary expenditures of over $1 billion across the US and Europe. To help surgeons reduce these follow-up surgeries, OncoRes Medical is developing a probe that detects residual tumor within the surgical cavity in real time using

Monday, 28 October 2019 / Tech23 Image: Dr Kath Giles, CEO of OncoRes Medical Except from article: We’re still buzzing from Australia’s national celebration of deeptech innovation that was held in Sydney last week on Wednesday 23 October! Companies from across the nation shared how they are tackling big challenges with quantum computing, next generation robots, clever climate change solutions, inspiring healthtech and so much more. This article was first published by Tech23

Friday, 28 June 2019 / Stephanie Palmer-Derrien / Smart Company OncoRes Chief Executive Katherine Giles with Co-Founders Brendan Kennedy and Christobel Saunders. Souce: Supplied. Excerpt from article: Medtech startup OncoRes has been selected to take part in the prestigious MedTech Innovator Accelerator program in the US, becoming the first ever Aussie company in the final 24 and making waves within the first few weeks. The startup beat some 818 applicants to make the fin

24 June 2019 / MedTech Innovator Leading Startup Awarded $25,000 Global Prize for its Intraoperative Handheld Imaging Tools to Identify and More Effectively Remove Tumor in Patients with Breast Cancer OncoRes CEO, Dr Kath Giles (front centre) receiving award. Excerpt from article: MedTech Innovator , the premier global nonprofit accelerator in the medical technology industry, today announced that OncoRes Medical , a medical device company developing an imaging tool to impro

Wednesday, 12 June 2019 Katherine Giles, OncoRes Medical at Pitch@Palace Australia 2.0 Australian start-up OncoRes was founded in 2016 to...

Thursday, 13 December 2018 / Briana Sherperd / ABC News The device can provide images of what could previously only be felt. (Supplied) Excerpt from article: Perth-based technology start-up OncoRes Medical has been internationally recognised for its work in attempting to improve the outcome of breast cancer surgery. The WA company was announced as one of three winners at the London-held finals of Pitch@Palace — a competition that identifies emerging start-ups from around

Wednesday, 7 November 2018 The finalists of the 2018 program were showcased at the ceremony using videos of their innovations. Emerging Innovation Category Finalist: OncoRes Medical - MRprobe - An Intraoperative Medical Imaging Device OncoRes Medical provides surgeons with a high resolution, handheld imaging probe to dramatically increase surgical accuracy and effectively remove tumour during surgery. The technology can substantially improve patient outcomes in breast-conserv